Method for Treatment of a Neurological Disease Characterized by Impaired Neuromodulator Function
- Detailed Technology Description
- The present invention relates to the field of neurological dysfunction and, more particularly to a neurological disease characterized by impairment of neuromodulator function, as in Parkinson's disease.
- *Abstract
-
A method for treatment of a mammalian neurological disease characterized by impaired neuromodulator function, the method comprises administering a therapeutically effective amount of a composition including a compound of a prenylcysteine or an analog thereof in a pharmaceutically acceptable carrier. The compound comprises a prenylcysteine or analog thereof selected from farnesylcysteine, N-acetylfarnesylcysteine, N-acetylgeranylcysteine, N-acetylfanesylcysteine, N-acetylgeranylcysteine, farnesyl2-mercaptoethanesulfonic acid, farnesylthioacetic acid, and farnesylmercaptosuccinic acid.
- Country/Region
- USA
For more information, please click Here
